SCHEMBL8869834

SCHEMBL8869834

COC(=O)CNC(=O)c1ccc(C(=O)NS(=O)(=O)c2cccc(CCNC(=O)c3ccccc3)c2)cn1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.48
SMN1; SMN2 Q16637 4/20 0.45
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
MAPT P10636 4/20 0.45
ALDH1A1 P00352 3/20 0.45
HIF1A Q16665 2/20 0.45
PPARA Q07869 1/20 0.45
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA7 P43166 3/20 0.44
CA9 Q16790 3/20 0.44
CA14 Q9ULX7 3/20 0.44
LMNA P02545 3/20 0.44
TP53 P04637 1/20 0.44
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869980 0.95 RAB9A (0.51) P4HTMSMN1; SMN2RAB9ANPC1ALDH1A1
SCHEMBL8869191 0.94 PPARA (0.48) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8867299 0.93 CA1 (0.43) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8868856 0.92 CA1 (0.51) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8868968 0.92 P4HTM (0.47) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8869157 0.91 P4HTM (0.50) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8869629 0.91 P4HTM (0.45) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8869839 0.91 P4HTM (0.46) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8868236 0.90 P4HTM (0.51) P4HTMSMN1; SMN2RAB9ANPC1MAPT
SCHEMBL8868562 0.90 P4HTM (0.51) P4HTMSMN1; SMN2RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed